Liver disease, coagulopathies and transfusion therapy.
作者信息
Mannucci Pier Mannuccio, Tripodi Armando
机构信息
Scientific Direction, IRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, Milan, Italy.
出版信息
Blood Transfus. 2013 Jan;11(1):32-6. doi: 10.2450/2012.0151-12. Epub 2012 Sep 12.
Abstract
摘要
相似文献
1
Liver disease, coagulopathies and transfusion therapy.
Blood Transfus. 2013 Jan;11(1):32-6. doi: 10.2450/2012.0151-12. Epub 2012 Sep 12.
2
Management of Coagulation and Anticoagulation in Liver Transplantation Candidates.
Liver Transpl. 2018 Aug;24(8):1119-1132. doi: 10.1002/lt.25198.
3
The Rebalanced Hemostasis System in End-stage Liver Disease and Its Impact on Liver Transplantation.
Int Anesthesiol Clin. 2017 Spring;55(2):107-120. doi: 10.1097/AIA.0000000000000139.
4
Ex vivo evaluation of 4 different viscoelastic assays for detecting moderate to severe coagulopathy during liver transplantation.
Liver Transpl. 2016 Apr;22(4):468-75. doi: 10.1002/lt.24379.
5
Intensive care unit management of liver-related coagulation disorders.
Crit Care Clin. 2012 Jul;28(3):389-98, vi. doi: 10.1016/j.ccc.2012.04.006. Epub 2012 May 9.
6
The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management.
Anesth Analg. 2018 Jan;126(1):46-61. doi: 10.1213/ANE.0000000000002394.
7
Acquired coagulopathies.
Crit Care Nurs Clin North Am. 1993 Sep;5(3):453-8.
8
Transfusion therapy in acquired coagulopathies.
Hematol Oncol Clin North Am. 1994 Dec;8(6):1181-201.
9
Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Clin Chest Med. 2003 Dec;24(4):607-22. doi: 10.1016/s0272-5231(03)00100-x.
10
Hyperviscosity syndromes and coagulopathies.
Semin Oncol. 1990 Apr;17(2):210-6.
引用本文的文献
1
Association of Adverse Perinatal Outcomes with Blood Components Transfusion in Patients with Acute Fatty Liver of Pregnancy.
Int J Womens Health. 2025 Jan 6;17:21-32. doi: 10.2147/IJWH.S477944. eCollection 2025.
2
Approach to thromboelastography-based transfusion in cirrhosis: An alternative perspective on coagulation disorders.
World J Gastroenterol. 2023 Mar 7;29(9):1460-1474. doi: 10.3748/wjg.v29.i9.1460.
3
Hemostatic Balance in Pediatric Acute Liver Failure: Epidemiology of Bleeding and Thrombosis, Physiology, and Current Strategies.
Front Pediatr. 2020 Dec 23;8:618119. doi: 10.3389/fped.2020.618119. eCollection 2020.
4
Clinical utility of viscoelastic testing in chronic liver disease: A systematic review.
World J Hepatol. 2020 Nov 27;12(11):1115-1127. doi: 10.4254/wjh.v12.i11.1115.
5
Comparison of Thromboelastography and Conventional Coagulation Tests in Patients With Severe Liver Disease.
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620925915. doi: 10.1177/1076029620925915.
6
Joint effect of pre-operative anemia and perioperative blood transfusion on outcomes of colon-cancer patients undergoing colectomy.
Gastroenterol Rep (Oxf). 2019 Aug 9;8(2):151-157. doi: 10.1093/gastro/goz033. eCollection 2020 Apr.
7
Transfusion strategies in patients with cirrhosis.
Eur J Haematol. 2020 Jan;104(1):15-25. doi: 10.1111/ejh.13342. Epub 2019 Nov 19.
8
Effects of Fibrinogen Levels and Platelet Counts on Viscoelastic Testing in Cirrhotic Patients.
J Crit Care Med (Targu Mures). 2018 Jul 1;4(3):90-95. doi: 10.2478/jccm-2018-0012. eCollection 2018 Jul.
9
Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study.
BMC Anesthesiol. 2018 Dec 22;18(1):198. doi: 10.1186/s12871-018-0664-8.
10
Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis.
Ann Lab Med. 2019 Mar;39(2):218-222. doi: 10.3343/alm.2019.39.2.218.
本文引用的文献
1
Tranexamic acid for upper gastrointestinal bleeding.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006640. doi: 10.1002/14651858.CD006640.pub2.
2
The coagulopathy of chronic liver disease.
N Engl J Med. 2011 Jul 14;365(2):147-56. doi: 10.1056/NEJMra1011170.
3
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
J Hepatol. 2011 Dec;55(6):1415-27. doi: 10.1016/j.jhep.2011.06.008. Epub 2011 Jun 28.
4
Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival.
Transplantation. 2011 Jun 15;91(11):1273-8. doi: 10.1097/TP.0b013e31821ab9f8.
5
Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma.
Intern Emerg Med. 2012 Apr;7(2):139-44. doi: 10.1007/s11739-011-0528-4. Epub 2011 Feb 5.
6
Platelet production and destruction in liver cirrhosis.
J Hepatol. 2011 May;54(5):894-900. doi: 10.1016/j.jhep.2010.08.018. Epub 2010 Dec 22.
7
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.
Blood. 2010 Aug 12;116(6):878-85. doi: 10.1182/blood-2010-02-261891. Epub 2010 Apr 16.
8
Management of varices and variceal hemorrhage in cirrhosis.
N Engl J Med. 2010 Mar 4;362(9):823-32. doi: 10.1056/NEJMra0901512.
9
A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation.
Clin Gastroenterol Hepatol. 2009 Sep;7(9):988-93. doi: 10.1016/j.cgh.2009.04.019. Epub 2009 May 4.
10
Liver biopsy.
Hepatology. 2009 Mar;49(3):1017-44. doi: 10.1002/hep.22742.
Zotero 插件